Haleon (HLN) analyst forecast and price target
Analyst forecast
Consensus of 17 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Upgraded | Equal-Weight → Overweight | — | Jan 23, 2026 |
| Barclays | Downgraded | Overweight → Equal-Weight | — | Sep 16, 2025 |
| Morgan Stanley | Maintained | Overweight | $10.95 from $9.90 | Sep 20, 2024 |
| Argus Research | Maintained | Buy | $10.00 | Mar 26, 2024 |
| Morgan Stanley | Initiated Coverage | Overweight | $9.00 | Nov 1, 2023 |
Frequently asked questions
Is HLN a buy, sell, or hold?
Analysts covering Haleon currently average a Buy rating: 10 buy, 5 hold and 2 sell, from 17 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on HLN?
On Jan 23, 2026, Barclays upgraded Haleon to Overweight.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.